FILTER
FILTERED INTERVIEW RESULTS
Rajiv Anand
FOUNDER AND CEO, QUARTIC.AI
"Digital transformation helps accelerate drug pipelines by reducing workload and increasing efficiency."
James Stephens and Darrell Tweidt
CLIENT SERVICES MANAGERS, PREMIER DRILLING CO.
"Experienced drillers who understand the local terrain are crucial for success."
Himanshu Gadgil
CEO, ENZENE BIOSCIENCES
"From an innovation point of view, breaking the US$40/gram cost barrier for production of mAbs is a key objective this year."
George Bee
PRESIDENT AND CEO, U.S. GOLD CORP
"We have a fully permitted project, significantly mitigating risk for potential investors. Our CK project will be the first gold mine in the state of Wyoming."
Mike Radomsky
PRESIDENT, CMC PHARMACEUTICALS
"We balance the need for speed in drug development with strict regulatory requirements by focusing on robust data, sound justifications and a well-structured technical package."
Andrea Confetti and Roberto Fanelli
EXCLUSIVE SYNTHESIS BU LEADER (AC) & CATALOGUE APIS BU LEADER (RF), DIPHARMA FRANCIS
"Small molecule drugs dominate pharmaceutical development, holding almost 60% of the market in 2024, and FDA approvals for small molecules are expected to stay strong."
Chris Dougherty
PRESIDENT AND CHAIRMAN, NORDMIN ENGINEERING
"Given the industry’s challenges, including cost increases and procurement delays, working as a team is essential."
Charles Kocsis
PROFESSOR & FORMER DEPARTMENT CHAIR - DEPARTMENT OF MINING ENGINEERING, THE UNIVERSITY OF UTAH
"Our focus is on advancing innovations in mine automation, efficient ventilation, mine design, and cooling systems to boost productivity and prioritize worker safety."
Donna LaVoie
FOUNDER AND CEO, LAVOIEHEALTHSCIENCE
"For biotechs, finding the balance between appealing to the public and institutional investors will be a challenge, much like trying to balance a recipe with the right mix of ingredients for the perfect dish."
Debbie Hart
PRESIDENT AND CEO, BIONJ
"New Jersey is home to eight of the top 10 global biopharmaceutical companies, nine of the top 10 R&D firms, and over 5,600 life sciences establishments. The State accounted for 43% of all novel FDA approvals in the past two years."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Ontario Mining and Toronto's Global Reach 2025 - Digital Interactive
2024 was marked a ‘super year’ for elections by the UN, with 72 countries and almost half the world’s population heading to the polls, impacting the global mining sector with each vote cast. This election uncertainty was accompanied by familiar issues for Ontario’s miners, with labor shortages, challenging equity markets, and cost inflation dominating the discourse of industry professionals across the value chain.
2024 was marked a ‘super year’ for elections by the UN, with 72 countries and almost half the world’s population heading to the polls, impacting the global mining sector with each vote cast. This election uncertainty was accompanied by familiar issues for Ontario’s miners, with labor shortages, challenging equity markets, and cost inflation dominating the discourse of industry professionals across the value chain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
